Author

Jeremy Mason

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

NRG-BR002: A Randomized Phase II/III Trial of Metastases-Directed Ablation with First-Line Systemic Therapy for Oligometastatic Breast Cancer

Purpose: Metastasis-directed therapy is increasingly used for oligometastatic breast cancer, despite its uncertain benefit during first-line systemic therapy. We evaluated whether metastasis-directed ablation improves progression-free survival (PFS) compared with first-line systemic therapy alone in patients with oligo...

S. Chmura, Kathryn A. Winter, W. Woodward et al. · Journal of Clinical Oncology · 0 citations

Open access Sep 2026

Enrichment-Free Rare Cell Profiling in Pediatric Osteosarcoma Reveals a Circulating Cell Population Associated with Relapse-Free Survival

Background: Outcomes for patients with osteosarcoma (OS) presenting with metastases at diagnosis or relapsed remain poor with five-year survival rate of only 20–30%. Risk stratification at diagnosis remains limited, and no validated prognostic liquid biopsy analyte currently exists for this disease. OS lacks the recurr...

Stephanie N. Shishido, Siddhant Chaudhary, Ian Ward et al. · Cancers · 0 citations